Current studies with PTK787, an oral inhibitor of vascular endothelial growth factor in colorectal cancer.
Klem
Jennifer
J
D000284:Administration, Oral; D020533:Angiogenesis Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use*; D017321:Clinical Trials, Phase I as Topic; D017322:Clinical Trials, Phase II as Topic; D017326:Clinical Trials, Phase III as Topic; D015179:Colorectal Neoplasms / Q000188:drug therapy*; D006801:Humans; D010793:Phthalazines / Q000008:administration & dosage / Q000627:therapeutic use*; D011725:Pyridines
D020533:Angiogenesis Inhibitors; D010793:Phthalazines; D011725:Pyridines; C404768:vatalanib